BioMarin Pharmaceutical | BMRN - هزینه PE به سود

قیمت سهام
55.32
تغییر روزانه
-0.73 -1.30%
ماهیانه
-12.77%
سالیانه
-22.43%
Q1 پیش بینی
56.74




Pe تغییر دادن تاریخ
Acadia Pharmaceuticals 11.61 2.09 2025-12
Agios Pharmaceuticals 3.56 0.68 2025-09
Alnylam Pharmaceuticals 170.7 367.33 2025-12
Amgen 25.31 15.82 2025-12
Bayer 5.93 0.68 2025-09
Biogen 14.02 4.63 2025-12
BioMarin Pharmaceutical 19.24 0.21 2025-12
Gilead Sciences 15.63 0.08 2025-12
Incyte 14.84 2.79 2025-12
Ionis Pharmaceuticals 396.15 79.28 2022-09
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 835.47 802.2 2025-12
PTC Therapeutics 9.98 3.25 2025-12
Puma Biotechnology 13.93 44.88 2024-06
Regeneron Pharmaceuticals 18.11 2.91 2025-12
Roche Holding 16.09 3.51 2025-12
Sanofi 15.75 1.53 2025-12
Sarepta Therapeutics 27.27 0 2025-09
United Therapeutics 17.32 1.62 2025-12
Vertex Pharmaceuticals 26.15 2.22 2025-12